Taken together, these data strongly indicate that STC2 negatively regulates MAOB expression via an un-characterized mechanism (Fig. 8K,L), and a combined analysis of both STC2 and MAOB levels is a potential approach in assessing the prognosis of patients with HCC. The gene discussed is MAOB; the disease is hepatocellular carcinoma.